BackgroundCheck.run
Search For

Wenbin Bin Ma, 683722 Sprigg St N, Frederick, MD 21704

Wenbin Ma Phones & Addresses

3722 Sprigg St N, Frederick, MD 21704    301-8744365   

6502 Mallery Ct, Frederick, MD 21703   

2112 Whitehall Rd, Frederick, MD 21702    301-6623860   

Walkersville, MD   

Mount Airy, MD   

Mentions for Wenbin Bin Ma

Wenbin Ma resumes & CV records

Resumes

Wenbin Ma Photo 18

Scientist

Location:
Frederick, MD
Work:
Fda
Scientist
Wenbin Ma Photo 19

Wenbin Ma

Wenbin Ma Photo 20

Wenbin Ma

Publications & IP owners

Us Patents

Methods And Compositions For Detecting Telomerase Activity

US Patent:
7390621, Jun 24, 2008
Filed:
Nov 12, 2003
Appl. No.:
10/534978
Inventors:
Jun Bao - Hacienda Heights CA, US
Hua Mao - Hacienda Heights CA, US
Wenbin Ma - Frederick MD, US
Lina Li - Germantown MD, US
Assignee:
Allied Biotech, Inc. - Ijamsville MD
International Classification:
C12Q 1/68
C12P 19/34
US Classification:
435 6, 435 911, 435 912
Abstract:
A method for determining telomerase activity using primer extension followed with real time PCR quantification is disclosed. The method of the present invention provides a rapid, sensitive and accurate measurement for telomerase activity in a biological sample. In one embodiment, the method includes the steps of: adding the biological sample to a reaction tube containing a first reaction mixture having a first primer and nucleoside triphosphates, a second reaction mixture having a second primer and a DNA polymerase, and a wax layer that separates the first reaction mixture from the second reaction mixture; incubating the biological sample with the first reaction mixture; admixing the extension product with the second reaction mixture; amplifying and quantifying the extension product using real-time PCR and a control template. In another embodiment, the detection method includes an in situ primer extension step that allows the production of the extension product within an intact cell. In this embodiment, the extension product can be preserved under appropriate conditions for an extended time before the completion of the quantification step.

Methods To Detect And Treat Diseases

US Patent:
2013013, May 23, 2013
Filed:
Apr 11, 2012
Appl. No.:
13/444201
Inventors:
Tianxin Wang - Burlingame CA, US
Wenbin Ma - Frederick MD, US
Lei Liu - Potomac MD, US
International Classification:
A61N 5/02
A61M 1/36
C12N 5/0781
A61N 5/06
US Classification:
600 1, 435 2, 604522, 607 88
Abstract:
The current invention discloses methods to treat disease caused by virus infection, bacterial infection, parasites infection, autoimmune disease, disease caused by production of unwanted antibodies, sepsis as well as methods to treat cancer and methods for virus infection detection using blood purification method. The current invention provides a method to treat pathogen infection by inactivating the pathogens in the blood. During the treatment, blood is withdrawn from a patient and is separated into its plasma and cellular components. The plasma portion is treated with physical means such as UV radiation to inactivate the pathogens inside and then is returned to the patient. The current invention also provide a method to treat cancer especially to prevent tumor metastasis and tumor recurrence by removing and/or inactivating (e.g. killing) the circulating tumor cells (CTC) in the blood after removing the tumor or treating the tumor with therapeutical means.

Model For Von Hippel-Lindau Disease

US Patent:
H002056, Dec 3, 2002
Filed:
Oct 4, 2001
Appl. No.:
09/971476
Inventors:
Laura S. Schmidt - Mt. Airy MD
Wenbin Ma - Frederick MD
Lino Tessarollo - Frederick MD
Berton Zbar - Garrett Park MD
Assignee:
The United States of America as represented by the Department of Health and Human Services - Washington DC
International Classification:
C07H 2104
US Classification:
536 231, 435183, 435325
Abstract:
Disclosed herein are nucleic acid molecules that can be used to effect a loss of function of the von Hippel-Lindau (VHL) allele in somatic and/or germ cells of a mammal and methods for using these molecules to create conditional VHL gene targeted and conditional VHL knockout animals. Disclosed herein are conditional VHL gene target vectors which, when inserted into an endogenous VHL gene, can result in deletion of an exon of a VHL gene by site-specific recombinaton when a recombinase is expressed conditionally.

Methods To Detect And Treat Diseases

US Patent:
2015028, Oct 8, 2015
Filed:
Apr 6, 2014
Appl. No.:
14/246117
Inventors:
Tianxin Wang - Burlingame CA, US
Wenbin Ma - Frederick MD, US
Lei Liu - Potomac MD, US
International Classification:
A61M 1/36
A61N 5/10
A61B 18/04
A61B 18/18
A61B 18/02
G01N 33/48
A61B 18/20
Abstract:
The current invention discloses methods to treat disease caused by virus infection, bacterial infection, parasites infection, autoimmune disease, disease caused by production of unwanted antibodies, sepsis as well as methods to treat cancer and methods for virus infection detection using blood purification method. The current invention provides a method to treat pathogen infection by inactivating the pathogens in the blood. During the treatment, blood is withdrawn from a patient and is separated into its plasma and cellular components. The plasma portion is treated with physical means such as UV radiation to inactivate the pathogens inside and then is returned to the patient. The current invention also provide a method to treat cancer especially to prevent tumor metastasis and tumor recurrence by removing and/or inactivating (e.g. killing) the circulating tumor cells (CTC) in the blood after removing the tumor or treating the tumor with therapeutical means.

Public records

Vehicle Records

Wenbin Ma

Address:
3722 Sprigg St N, Frederick, MD 21704
VIN:
JTEHW21A870038425
Make:
TOYOTA
Model:
HIGHLANDER HYBRID
Year:
2007

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.